Search clinical trials for: Xalatan 0.005% eye drops

Total 598 results

Allergan

Completed

Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Efficacy and Tolerability of Xalatan in Patients (A6111128)

Ocular Hypertension | Glaucoma

Egypt, Saudi Arabia, United Arab Emirates
Allergan

Completed

Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues

Ocular Hypertension | Open Angle Glaucoma

United States
Allergan

Completed

Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%

Ocular Hypertension | Glaucoma

United States
Alcon Research

Completed

A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin

Glaucoma

United States
University of Miami
Pfizer

Completed

Relationship Between Eye Pressure and Ganglion Cell Function in Eyes Receiving Latanoprost Versus Placebo

Glaucoma

United States
Allergan

Completed

Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

Dry Eye Syndromes

United States
Alcon Research

Completed

Efficacy Study of Travoprost APS Versus TRAVATAN

Ocular Hypertension | Open Angle Glaucoma
Kasr El Aini Hospital

Completed

Comparison Between Latanoprost , Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG Patients

Primary Open Angle Glaucoma

Egypt
Alcon Research

Completed

Efficacy of Systane Ultra in Post Menopausal Women With Dry Eye

Post Menopausal Dry Eye Subjects
Alcon Research

Completed

Acute Comfort of Lubricant Eye Drop FID 111421

Dry Eye
Alcon Research

Completed

Adherence Assessment With Travalert Dosing Aid

Ocular Hypertension | Open-angle Glaucoma

Spain
Taejoon Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes

Dry Eye Syndromes

Korea, Republic of
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients

Dry Eye

United States
Ophthalmic Consultants of Connecticut

Unknown

Patient Satisfaction and Tear Osmolarity With the Use of Blink Tears, Blink Gel Tears and Systane Balance

Dry Eye

United States
Ospedale San Raffaele
Dompé Farmaceutici S.p.A

Completed

Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema (NEMO)

Retinitis Pigmentosa | Cystoid Macular Edema

Italy
Allergan

Completed

Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%

Ocular Hypertension | Glaucoma

United States
Alcon Research

Completed

An Evaluation of the Daytime Use of an Investigational Lubricant Eye Drop

Dry Eye
Augusta University
Pfizer

Unknown

Effects of Xal-Ease on Patient Compliance With Xalatan (Xal-Ease)

Glaucoma

United States
Hai Yen Eye Care
Brien Holden Vision Institute

Completed

Myopia Control With Novel Eye Drops

Myopia

Vietnam
Alcon Research

Completed

An Evaluation of the Nighttime Retention of Effect of an Investigational Lubricant Eye Drop (FID 115958D)

Dry Eye
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical...

Recruiting

Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects

Corneal Defect

China
Tufts Medical Center

Completed

The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED

Dry Eye Disease

United States
Summa Health System

Completed

The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye

Glaucoma | Application Site Pigmentation Changes

United States
Medical University of Vienna

Completed

Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome

Dry Eye Syndromes

Austria
Santen Oy

Completed

Pharmacokinetics, Safety and Tolerability of the Preservative-free Fixed Dose Combination of Tafluprost 0.0015% and Timolol 0.5% Eye Drops

Healthy Volunteers

Finland
Alcon Research

Completed

Acute Comfort and Blurring Profile Evaluation of Marketed Lubricant Eye Drops

Dry Eye

United States
Alcon Research

Completed

Acute Comfort and Blur of Systane and Optive

Dry Eye
Alcon Research

Completed

Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Lubricant Eye Gel

Dry Eye
Alcon Research

Completed

The Effect of Systane Ultra Lubricant Eye Drops (FID 112903) on Visual Performance

Dry Eye

United States
Allgenesis Biotherapeutics Inc.

Completed

A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia (SURPH)

Pterygium

Australia
Fovea Pharmaceuticals SA

Completed

Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy

Diabetic Macular Edema

United States, Australia, Belgium, Czech Republic, France, Germany, Israel, Italy, Poland, Spain
Alcon Research

Completed

Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health

Ocular Hypertension | Open Angle Glaucoma
Alcon Research

Completed

Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION

Dry Eye
Vanderbilt-Ingram Cancer Center

Terminated

Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System

Thyroid Carcinoma | Radioactive Iodine Level

United States
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical...

Completed

ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial

Corneal Epithelial Defect

China
Alcon Research

Completed

Acute Comfort of Lubricant Eye Drops FID 112903

Dry Eye

United States
Alcon Research

Completed

Acute Comfort and Blur of Systane Ultra and Systane

Dry Eye

United States
Allergan

Completed

A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

Dry Eye Disease

France, Spain, Russian Federation, Belgium, Germany, Italy, United Kingdom, Australia
Alcon Research

Withdrawn

Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time

Dry Eye
Alcon Research

Completed

Fluorophotometry Evaluation of Lubricant Eye Drops

Healthy

United States
Aristotle University Of Thessaloniki

Completed

Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure (CCT-IOP)

Ocular Hypertension | Open Angle Glaucoma

Greece
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Open Angle Glaucoma

France
Jiangsu HengRui Medicine Co., Ltd.

Completed

Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction

Treatment of Dry Eye Disease With Meibomian Gland Dysfunction

China
Alcon Research

Completed

Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Eye Ointment

Dry Eye
Yale University
Pfizer

Completed

Effect of Age on Latanoprost 0.005% in Patients With Glaucoma

Glaucoma

United States
Alcon Research

Completed

Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical...

Completed

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops (TPRK)

Corneal Epithelium Defect

China
Tarsier Pharma

Completed

A Study of TRS01 in Participants With Post-surgical Ocular Inflammation

Post Surgical Ocular Inflammation

United States
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of Two Marketed Artificial Tears in Non-contact Lens Wearing Patients

Visual Acuity

United Kingdom

3

Subscribe